Role of Metallic Nanoparticles in the Treatment of Diabetes Mellitus

Y. Kumari, Gurmandeep Kaur, Clarisse Ayinkamiye, S. Singh, R. Kumar, R. Khursheed
{"title":"Role of Metallic Nanoparticles in the Treatment of Diabetes Mellitus","authors":"Y. Kumari, Gurmandeep Kaur, Clarisse Ayinkamiye, S. Singh, R. Kumar, R. Khursheed","doi":"10.35652/igjps.2019.92s19","DOIUrl":null,"url":null,"abstract":"Diabetes mellitus (DM) is a well-known threat to mankind for more than 2000 years. DM is a group of metabolic disorder characterized by a complete lack of insulin, a relative lack of insulin, or insulin resistance. The prevalence of diabetes is rapidly rising all over the globe at an alarming rate and as per international diabetes federation (IDF); diabetes is expected to become the seventh largest cause of death worldwide by 2030. Treatment of diabetes need constant monitoring of blood glucose level, regulating it through modified dietary sugar intake and insulin therapy. Current dosage of injectable insulin comprises of up to twothree subcutaneous injections per day which can cause psychological stress leading to poor patient compliance. At present several researchers have been focusing on new management options for diabetes. Among these options the use of metallic nanoparticles is becoming an eye catching and most promising due to their non-invasiveness and site specificity. Metallic nanoparticles hold substantial potential for improving the care of patients with diabetes as it allows oral delivery of insulin to the specific site thus increasing its bioavailability and pharmacological efficacies. The current presentation focuses on oral delivery of insulin using metallic nanoparticles. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Kumari, Y.; Kaur, G.; Ayinkamiye, C.; Singh, S.K.; Kumar, R.; Khursheed, R. Role of Metallic Nanoparticles in the Treatment of Diabetes Mellitus. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 121. DOI: http://doi.org/10.35652/IGJPS.2019.92S19 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"15 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indo Global Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35652/igjps.2019.92s19","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Diabetes mellitus (DM) is a well-known threat to mankind for more than 2000 years. DM is a group of metabolic disorder characterized by a complete lack of insulin, a relative lack of insulin, or insulin resistance. The prevalence of diabetes is rapidly rising all over the globe at an alarming rate and as per international diabetes federation (IDF); diabetes is expected to become the seventh largest cause of death worldwide by 2030. Treatment of diabetes need constant monitoring of blood glucose level, regulating it through modified dietary sugar intake and insulin therapy. Current dosage of injectable insulin comprises of up to twothree subcutaneous injections per day which can cause psychological stress leading to poor patient compliance. At present several researchers have been focusing on new management options for diabetes. Among these options the use of metallic nanoparticles is becoming an eye catching and most promising due to their non-invasiveness and site specificity. Metallic nanoparticles hold substantial potential for improving the care of patients with diabetes as it allows oral delivery of insulin to the specific site thus increasing its bioavailability and pharmacological efficacies. The current presentation focuses on oral delivery of insulin using metallic nanoparticles. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Kumari, Y.; Kaur, G.; Ayinkamiye, C.; Singh, S.K.; Kumar, R.; Khursheed, R. Role of Metallic Nanoparticles in the Treatment of Diabetes Mellitus. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 121. DOI: http://doi.org/10.35652/IGJPS.2019.92S19 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
金属纳米颗粒在糖尿病治疗中的作用
糖尿病(DM)是一个众所周知的威胁人类超过2000年。糖尿病是一组以完全缺乏胰岛素、相对缺乏胰岛素或胰岛素抵抗为特征的代谢紊乱。全球糖尿病患病率正以惊人的速度迅速上升,根据国际糖尿病联合会(IDF);预计到2030年,糖尿病将成为全球第七大死因。糖尿病的治疗需要持续监测血糖水平,通过调整饮食糖摄入量和胰岛素治疗来调节血糖水平。目前注射胰岛素的剂量包括每天多达两到三次皮下注射,这可能造成心理压力,导致患者依从性差。目前,一些研究人员一直在关注糖尿病的新管理选择。在这些选择中,金属纳米颗粒的使用因其非侵入性和部位特异性而成为最引人注目和最有前途的选择。金属纳米颗粒具有改善糖尿病患者护理的巨大潜力,因为它允许将胰岛素口服到特定部位,从而提高其生物利用度和药理功效。目前的研究重点是使用金属纳米颗粒口服胰岛素。©2019 igglobal研究与出版基金会。版权所有。本文出处:Kumari, Y.;考尔,g;Ayinkamiye c;辛格”栏目;库马尔,r;金属纳米颗粒在糖尿病治疗中的作用。印度国际制药公司。科学。, 2019;9(2生理):121。DOI: http://doi.org/10.35652/IGJPS.2019.92S19。印度全球药物科学杂志(ISSN 2249 1023;CODENIGJPAI;NLM ID: 101610675)在CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index哥白尼,Google Scholar等中索引和摘要。欲了解更多详情,请访问http://iglobaljournal.com这是由APTI赞助,印度旁遮普阿姆利则马纳瓦拉斯里赛药学院组织的“RAPSCON-2019”的特刊。以日志形式提供放松。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Microsponge as Novel Drug Delivery System: A Review Disporum Cantoniense(Lour.) Merr.: An Overview and Study of Traditional Use Carbapenemase Detection Among Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates Using a Modified Blue-Carba Test Effect of Polymers in the Design and Characterization of Sustained Release Aceclofenac Microspheres Human Monkeypox-An Update
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1